MEETING DATES: all times local eastern standard time (EST)
-
Wednesday, September 27 - Virtual AM Only
-
Thursday, September 28th - Virtual AM Only
- Thursday, September 28th - Hybrid 5PM EST
-
5:00 PM Welcome Address
-
6:00PM-8:00 PM Welcome Reception
-
-
Friday, September 29th - Hybrid
-
Saturday, September 30th - Hybrid
Exhibitor & Poster Hall Hours:
Friday 12:35PM - 1:35PM
Friday 4:00PM - 5:00PM
Saturday 1:00PM - 2:00PM
Poster Hall will be available online 9/29.
Letter from Our Executive Chair
Welcome to the 2023 NICER Hybrid Symposium, “Where the Wild Cells Are: Understanding How Disruptions in the Immune System Impact Hematopoiesis,” hosted in Pittsburgh, PA. We are excited to have you join us either in-person or virtually as we explore the raucous (sometimes seemingly over-imaginative) immune system as it tests the limits of hematopoiesis and our ability to tame the wild cells. As in past years, the 2023 symposium is delighted to continue audience favorites such as the “Pro-Con Debates” and “Tales of the Case Conference” where we will emphasize the multi-specialty nature of immuno-heme disorders and highlight recent advances along with ongoing knowledge gaps. A special in- person version of the “Speed Networking” will be hosted for in-person attendees as well as entertaining evening events. Additionally, we are continuing our focus on giving back to both our academic peers and the patient communities via a Wednesday morning virtual patient-facing session hosted by Race for Immunology and a Thursday morning virtual “Immuno-Heme 101” session highlighting common symptoms and counseling needs encountered by primary care providers and subspecialists alike when caring for our rare disease patients.
Looking forward to seeing you at the symposium!
Symposium Planning Committee
Hey Chong, MD PhD
UPMC CHILDRENS PITTSBURGH
Ram Kalpatthi, MD
UPMC CHILDRENS PITTSBURGH
Andrea Griffith, NP
UNIVERSITY OF MICHIGAN
Linda McAllister, MD PhD
UPMC CHILDRENS PITTSBURGH
Evelyn Argirokastritis
RACE FOR IMMUNOLOGY
Kara Coffey, MD
UPMC CHILDRENS PITTSBURGH
Michelle Downer
UNIVERSITY OF MICHIGAN
Kelly Walkovich, MD
EDUCATIONAL PLANNER
NICER EXECUTIVE CHAIR
Melissa Rose, DO
NICER EDUCATION CHAIR
Claiming CME
Continuing Medical Education Information
The 2023 NICER symposium offers a venue for multi-specialty discussion of immuno-hematologic disorders with a focus this year on disorders of immune dysregulation. Participants will have the opportunity to participate in interactive sessions directed at primary care recognition and management of immuno-heme disorders, learn about emerging phenotypes and new management strategies for immune dysregulation from national experts and participate in active patient case reviews, topic debates as well as learn new skills for career development in rare disease. Clinical immunologists will apply triaging skills to recognize and diagnose emerging phenotypes and disorders of immune dysregulation. Additionally, clinical immunologists will utilize knowledge learned to select biologically rational management strategies. Primary care providers will identify warning signs of an underlying immune disorder and provide initial management of immune disorders.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Michigan Medical School and North American Immuno-Hematology Clinical Education and Research Consortium.
The University of Michigan Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Michigan Medical School designates this live activity for a maximum of 18.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Target Audience: Physicians
Learning Objectives:
1. Identify patients with autoimmune symptoms at risk for underlying inborn errors of immunity and prioritize them for further immune evaluation.
2. Describe the impact of the immune system on hematopoiesis.
3. Illustrate the benefits of a multi-specialty approach to the care of patients with disorders of immune dysregulation
Expected Results:
Clinical immunologists will apply triaging skills to identify patients with autoimmune symptoms at risk for underlying inborn errors of immunity and prioritize them for further immune evaluation. Additionally, clinical immunologists will utilize knowledge learned to determine biologically rational management strategies. Primary care providers will practice identifying warning signs of an underlying immune dysregulation disorders and how to provide initial management of immune disorders.
For the complete list of faculty, the detailed agenda for sessions, and contact information, visit: Michigan Medicine (highmarksce.com)